Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Chrysanthi, Sardeli"'
Autor:
Paul Zarogoulidis, Dimitris Matthaios, Panagoula Oikonomou, Christina Nikolaou, Charalampos Charalampidis, Chrysanthi Sardeli
Publikováno v:
Cancer Treatment and Research Communications, Vol 37, Iss , Pp 100757- (2023)
Non-small cell lung cancer is still diagnosed at a late disease stage and systematic therapy is necessary. Currently we have three main treatment modalities; chemotherapy, targeted with tyrosine kinase inhibitors and immune check point inhibitors. In
Externí odkaz:
https://doaj.org/article/a826e5ef7af34f75aef1fc84b1c70839
Autor:
Paul Zarogoulidis, Dimitris Matthaios, Panagoula Oikonomou, Christina Nikolaou, Charalampos Charalampidis, Chrysanthi Sardeli
Publikováno v:
Cancer Treatment and Research Communications, Vol 37, Iss , Pp 100762- (2023)
Lung cancer is usually diagnosed at advanced stage and systematic therapy is administered. New current diagnostic techniques such as the convex-endobronchial ultrasound, radial endobronchial ultrasound, cone beam ct, electromagnetic navigation and ro
Externí odkaz:
https://doaj.org/article/7db7c836f1b54fc4a9145fee825f4534
Autor:
Christos Arnaoutoglou, Kalliopi Dampala, Christos Anthoulakis, Evangelos G. Papanikolaou, Ioannis Tentas, Georgios Dragoutsos, Nikolaos Machairiotis, Paul Zarogoulidis, Aristeidis Ioannidis, Dimitris Matthaios, Eleni I. Perdikouri, Dimitrios Giannakidis, Chrysanthi Sardeli, Stamatios Petousis, Panagoula Oikonomou, Christina Nikolaou, Charalampos Charalampidis, Konstantinos Sapalidis
Publikováno v:
Medicina, Vol 59, Iss 7, p 1183 (2023)
Ovarian cancer is a malignant disease that affects thousands of patients every year. Currently, we use surgical techniques for early-stage cancer and chemotherapy treatment combinations for advanced stage cancer. Several novel therapies are currently
Externí odkaz:
https://doaj.org/article/187adfdf10ba4ac89c721ec276e049c4
Autor:
Daliborka Bursac, Bojan Zarić, Tomi Kovačević, Vladimir Stojšić, Anastasios Vagionas, Ioannis Boukovinas, Kosmas Tsakiridis, Christoforos Kosmidis, Konstantinos Sapalidis, Konstantinos Romanidis, Nikolaos Courcoutsakis, Dimitris Matthaios, Paul Zarogoulidis, Chrysanthi Sardeli, Vanesa Sekerus
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 716-724 (2021)
Traditionally, tissue availability from rebiopsy is a prerequisite for adequate sequencing of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in therapy for advanced-stage lung cancer. Tissue biopsy truly is the gold standard
Externí odkaz:
https://doaj.org/article/f345fecc4a12422d8fd4ac6c820843ba
Autor:
Paul Zarogoulidis, Dimitris Matthaios, Haidong Huang, Chong Bai, Wolfgang Hohenforst-Schmidt, Konstantinos Porpodis, Dimitris Petridis, Konstantinos Pigakis, Nikolaos Kougkas, Panagoula Oikonomou, Christina Nikolaou, Dimitris Hatzibougias, Chrysanthi Sardeli
Publikováno v:
Medicina, Vol 59, Iss 4, p 787 (2023)
Background and Objectives: Interstitial lung diseases have always been an issue for pulmonary and rheumatology physicians. Computed tomography scans with a high-resolution protocol and bronchoalveolar lavage have been used along with biochemical bloo
Externí odkaz:
https://doaj.org/article/a3e64ee0e8f34246b49ad97e17b76d1a
Autor:
Eleni Stamoula, Spyridon Siafis, Ioannis Dardalas, Alexandra Ainatzoglou, Alkis Matsas, Theodoros Athanasiadis, Chrysanthi Sardeli, Konstantinos Stamoulas, Georgios Papazisis
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundIncreased prevalence of depression has been observed among patients with multiple sclerosis (MS) and correlated with the elevated levels of proinflammatory cytokines and the overall deregulation of monoaminergic neurotransmitters that these
Externí odkaz:
https://doaj.org/article/85ca8b0f6b52455480cbe824a1e3fa7c
Autor:
Chrysanthi Sardeli, Paul Zarogoulidis, Konstantinos Romanidis, Panagoula Oikonomou, Konstantinos Sapalidis, Haidong Huang, Chong Bai, Wolfgang Hohenforst-Schmidt, Kosmas Tsakiridis, Bojan Zaric, Branislav Perin, Aris Ioannidis, Sofia Baka, Konstantinos Drevelegas, Maria Kosmidou, Christoforos Kosmidis
Publikováno v:
Respiratory Medicine Case Reports, Vol 31, Iss , Pp 101258- (2020)
Nowadays we have novel therapies for advanced stage non-small cell lung cancer. Immunotherapy has been introduced in the market for several years and until now its administration is mostly based on the programmed death-ligand 1. First line treatment
Externí odkaz:
https://doaj.org/article/c8aa0a929ad74b30ad3a05d06ceb9ddd
Autor:
Paul Zarogoulidis, Christoforos Kosmidis, Konstantinos Sapalidis, Wolfgang Hohenforst-Schmidt, Dimitris Matthaios, Kosmas Tsakiridis, Aimilios Lallas, Chong Bai, Haidong Huang, Christos Arnaoutoglou, Aris Ioannidis, Chrysanthi Sardeli
Publikováno v:
Frontiers in Bioscience-Landmark, Vol 27, Iss 1, p 036 (2022)
Introduction: Local treatment of the airways and lung parenchyma has been used in clinical practice for several years for a variety of diseases. Methods: A variety of endoscopic tools for local treatment exist, especially for treating malignancies. U
Externí odkaz:
https://doaj.org/article/047bbc83a4304302822890777a118658
Autor:
Paul Zarogoulidis, Panos Chinelis, Anastasia Athanasiadou, Theodora Tsiouda, Georgia Trakada, Anastasios Kallianos, Lemonia Veletza, Dimitris Hatzibougias, Electra Mihalopoulou, Eirini Goupou, Christoforos Kosmidis, Chrysanthi Sardeli, Haidong Huang, Wolfgang Hohenforst-Schmidt
Publikováno v:
Respiratory Medicine Case Reports, Vol 22, Iss C, Pp 101-105 (2017)
In the past decade novel agents are on the market for non-small cell lung cancer adenocarcinoma based on pharmacogenomics. The epidermal growth factor receptor mutation, anaplastic lymphoma kinase and programmed death-ligand 1 investigation is necess
Externí odkaz:
https://doaj.org/article/ff8eb82fa4214f9ea0f978d1786f1fdc
Autor:
Paul Zarogoulidis, Aggeliki Rapti, Chrysanthi Sardeli, Panagiotis Chinelis, Anastasia Athanasiadou, Katerina Paraskevaidou, Anastasios Kallianos, Lemonia Veletza, Georgia Trakada, Wolfgang Hohenforst-Schmidt, Haidong Huang
Publikováno v:
Respiratory Medicine Case Reports, Vol 21, Iss C, Pp 171-175 (2017)
Guidelines for the treatment of non-small cell lung cancer adenocarcinoma positive in epidermal growth factor mutations indicate tyrosine kinase inhibitors. There are currently three tyrosine kinase inhibitors that can be used as first line treatment
Externí odkaz:
https://doaj.org/article/f3efa50b05d44e4383eb088185a9286c